Cleviprex Recall Issued Due to Stainless Steel Particles
The FDA announced a recall of Cleviprex on Thursday, indicating that certain lots of the hypertension drug may be contaminated with stainless steel particles that could reduce blood flow and lead to potentially lead to serious injury.
Cleviprex (clevidipine butyrate) is an intravenously-delivered drug used to reduce blood pressure, manufactured by The Medicines Company. The Cleviprex recall was issued after visible particles were found in vials during an annual inspection.
“If the particles were to aggregate, or if larger particles were present, then they could theoretically reduce blood flow in capillaries, cause mechanical damage to some tissues, or initiate acute or chronic inflammatory reactions,” warned the FDA in a statement posted December 17, 2009. “Reduced blood supply to tissues may lead to ischemia or organ insufficiency in the brain, kidney, liver, heart or lungs.”
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
There have been no injuries reported in association with the contaminated Cleviprex vials.
The recall affects the following 11 lots of Cleviprex injectable emulsion: 61-978-DW, 61-979-DW, and 61-980-DW, Exp. 01/2010; 68-404-DJ, 68-405-DJ, and 68-406-DJ, Exp. 08/2010; 69-830-DJ, 63-385-DJ, 63-386-DJ, and 63-266-DJ, Exp 03/2011; and 64-453-DJ, Exp. 04/2011. The recall is limited to these lots.
Any health care professionals with recalled lots of Cleviprex in their inventory should return the product to the pharmaceutical distributor or wholesaler where it was purchased. The Medicines Company is currently shipping additional batches from unaffected lots to wholesalers.
Any adverse reactions from the use of Cleviprex should be reported to the FDA’s MedWatch Program at www.fda.gov/medwatch.
"*" indicates required fields
More Top Stories
A federal judge has announced he will soon begin remanding 3M earplug lawsuits back to their originating districts for trials over claims of veteran hearing loss.
Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states
A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.